MiR-124-3p Attenuates Hyperphosphorylation of Tau Protein-Induced Apoptosis Via Caveolin-1-pi3k/akt/gsk3β Pathway in N2a/APP695swe Cells
Qingmei Kang,Yue Xiang,Dan Li,Jie Liang,Xiong Zhang,Fanlin Zhou,Mengyuan Qiao,Yingling Nie,Yurong He,Jingyi Cheng,Yubing Dai,Yu Li
DOI: https://doi.org/10.18632/oncotarget.15149
2017-01-01
Oncotarget
Abstract:Hyperphosphorylation of Tau forming neurofibrillary tangles has been considered as a crucial event in the pathogenesis of Alzheimer's disease (AD). MiR-124-3p belongs to microRNA (miRNA) family and was markedly decreased in AD, however, the functions of miR-124-3p in the pathogenesis of AD remain unknown. We observed that the expression of miR-124-3p was significantly decreased in N2a/APP695swe cells; and transfection of miR-124-3p mimics not only attenuated cell apoptosis and abnormal hyperphosphorylation of Tau protein without any changes of total Tau protein, but also increased expression levels of Caveolin-1, phosphoinositide 3-kinase (PI3K), phospho-Akt (Akt-Ser473)/Akt, phospho-glycogen synthase kinase-3 beta (GSK-3β-Ser9)/GSK-3β in N2a/APP695swe cells. We further found that miR-12-3p directly targeted Caveolin-1; miR-124-3p inhibited abnormal hyperphosphorylation of Tau by regulating Caveolin-1-PI3K/Akt/GSK3β pathway in AD. This study reveals that miR-124-3p may play a neuroprotective role in AD, which may provide new ideas and therapeutic targets for AD.
What problem does this paper attempt to address?